Data-Driven Mathematical Modeling and Dynamical Analysis for SARS-CoV-2 Coinfection with Bacteria
暂无分享,去创建一个
Xiufen Zou | Yu Zhou | Mingzhan Huang | Ying'an Jiang | Xiufen Zou | Mingzhan Huang | Yu Zhou | Ying'an Jiang
[1] Tangchun Wu,et al. Reconstruction of the full transmission dynamics of COVID-19 in Wuhan , 2020, Nature.
[2] P. Rieu,et al. Neutrophils: Molecules, Functions and Pathophysiological Aspects , 2000, Laboratory Investigation.
[3] G. Herrler,et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.
[4] Yang Kuang,et al. Dynamics of a delay differential equation model of hepatitis B virus infection , 2008, Journal of biological dynamics.
[5] W. Liles,et al. The phagocytes: neutrophils and monocytes. , 2008, Blood.
[6] Johannes Zierenberg,et al. Inferring change points in the spread of COVID-19 reveals the effectiveness of interventions , 2020, Science.
[7] Yuxiao Song,et al. Clinical characteristics of 82 cases of death from COVID-19 , 2020, PloS one.
[8] F. Rombouts,et al. Modeling of the Bacterial Growth Curve , 1990, Applied and environmental microbiology.
[9] France Gauvin,et al. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[10] S. Perlman,et al. COVID-19 Treatments and Pathogenesis Including Anosmia in K18-hACE2 mice , 2020, Nature.
[11] S. Akira,et al. Pathogen Recognition and Innate Immunity , 2006, Cell.
[12] Judit Zsuga,et al. The Hill equation and the origin of quantitative pharmacology , 2012 .
[13] Edda Klipp,et al. Systems Biology in Practice , 2005 .
[14] Bharath Srinivasan,et al. Words of advice: teaching enzyme kinetics , 2020, The FEBS journal.
[15] Carl Nathan,et al. Neutrophils and immunity: challenges and opportunities , 2006, Nature Reviews Immunology.
[16] Uri Alon,et al. An Introduction to Systems Biology , 2006 .
[17] W. Wang,et al. Viral and host factors related to the clinical outcome of COVID-19 , 2020, Nature.
[18] Shamus P. Keeler,et al. SARS-CoV-2 infection of hACE2 transgenic mice causes severe lung inflammation and impaired function , 2020, Nature Immunology.
[19] Eric Song,et al. Longitudinal analyses reveal immunological misfiring in severe COVID-19 , 2020, Nature.
[20] Roland Eils,et al. COVID-19 severity correlates with airway epithelium–immune cell interactions identified by single-cell analysis , 2020, Nature Biotechnology.
[21] Akiko Iwasaki,et al. Innate immunity to influenza virus infection , 2014, Nature Reviews Immunology.
[22] Theodora Psaltopoulou,et al. Hematological findings and complications of COVID‐19 , 2020, American journal of hematology.
[23] J. M. Crawford,et al. Targeting potential drivers of COVID-19: Neutrophil extracellular traps , 2020, The Journal of experimental medicine.